Huntingtin Aggregates in the Olfactory Bulb in Huntington's Disease
- PMID: 33013352
- PMCID: PMC7461834
- DOI: 10.3389/fnagi.2020.00261
Huntingtin Aggregates in the Olfactory Bulb in Huntington's Disease
Abstract
Olfactory deficits are an early and prevalent non-motor symptom of Huntington's disease (HD). In other neurodegenerative diseases where olfactory deficits occur, such as Alzheimer's disease and Parkinson's disease, pathological protein aggregates (tau, β-amyloid, α-synuclein) accumulate in the anterior olfactory nucleus (AON) of the olfactory bulb (OFB). Therefore, in this study we determined whether aggregates are also present in HD OFBs; 13 HD and five normal human OFBs were stained for mutant huntingtin (mHtt), tau, β-amyloid, TDP-43, and α-synuclein. Our results show that mHtt aggregates detected with 1F8 antibody are present within all HD OFBs, and mHtt aggregate load in the OFB does not correlate with Vonsattel grading scores. The majority of the aggregates were located in the AON and in similar abundance in each anatomical segment of the AON. No mHtt aggregates were found in controls; 31% of HD cases also contained tau neurofibrillary tangles within the AON. This work demonstrates HD pathology in the OFB and indicates that disease-specific protein aggregation in the AON is a common feature of neurodegenerative diseases that show olfactory deficits.
Keywords: Huntington’s disease; anterior olfactory nucleus; huntingtin aggregates; olfactory bulb; tau.
Copyright © 2020 Highet, Dieriks, Murray, Faull and Curtis.
Figures



Similar articles
-
Co-occurrence of mixed proteinopathies in late-stage Huntington's disease.Acta Neuropathol. 2018 Feb;135(2):249-265. doi: 10.1007/s00401-017-1786-7. Epub 2017 Nov 13. Acta Neuropathol. 2018. PMID: 29134321
-
Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.Brain Pathol. 2014 Mar;24(2):152-65. doi: 10.1111/bpa.12088. Epub 2013 Oct 28. Brain Pathol. 2014. PMID: 24033473 Free PMC article.
-
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.Neuropathol Appl Neurobiol. 2003 Oct;29(5):503-10. doi: 10.1046/j.1365-2990.2003.00453.x. Neuropathol Appl Neurobiol. 2003. PMID: 14507342
-
The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases.Transl Neurodegener. 2020 Jun 3;9(1):22. doi: 10.1186/s40035-020-00200-7. Transl Neurodegener. 2020. PMID: 32493457 Free PMC article. Review.
-
Implications of Tau Dysregulation in Huntington's Disease and Potential for New Therapeutics.J Huntingtons Dis. 2023;12(1):1-13. doi: 10.3233/JHD-230569. J Huntingtons Dis. 2023. PMID: 37092231 Free PMC article. Review.
Cited by
-
Spatial Multi-Omics in Alzheimer's Disease: A Multi-Dimensional Approach to Understanding Pathology and Progression.Curr Issues Mol Biol. 2024 May 20;46(5):4968-4990. doi: 10.3390/cimb46050298. Curr Issues Mol Biol. 2024. PMID: 38785566 Free PMC article. Review.
-
Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.Mol Neurobiol. 2022 Jul;59(7):4257-4273. doi: 10.1007/s12035-022-02851-1. Epub 2022 May 3. Mol Neurobiol. 2022. PMID: 35505049 Review.
-
Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment.J Neuropathol Exp Neurol. 2022 Jul 19;81(8):643-649. doi: 10.1093/jnen/nlac042. J Neuropathol Exp Neurol. 2022. PMID: 35751438 Free PMC article.
-
Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer's and Parkinson's disease patients.Commun Biol. 2022 Jan 24;5(1):88. doi: 10.1038/s42003-022-03032-5. Commun Biol. 2022. PMID: 35075270 Free PMC article.
-
Olfactory Dysfunction in Huntington's Disease.J Huntingtons Dis. 2021;10(4):413-422. doi: 10.3233/JHD-210497. J Huntingtons Dis. 2021. PMID: 34719504 Free PMC article. Review.
References
-
- Bassil F., Brown H. J., Pattabhiraman S., Iwasyk J. E., Maghames C. M., Meymand E. S., et al. (2020). Amyloid-Beta (Aβ) plaques promote seeding and spreading of alpha-synuclein and Tau in a mouse model of lewy body disorders with Aβ pathology. Neuron 105 260–275.e6. 10.1016/j.neuron.2019.10.010 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources